Kazemeini, Elahe
Op de Beeck, Sara
Vroegop, Anneclaire
Van Loo, Dorine
Willemen, Marc
Verbraecken, Johan
Braem, Marc J.
Vanderveken, Olivier M.
Dieltjens, Marijke http://orcid.org/0000-0002-5822-1960
Funding for this research was provided by:
Fonds Wetenschappelijk Onderzoek (12H4520N, 1299822N)
Article History
Received: 22 October 2021
Revised: 24 December 2021
Accepted: 5 January 2022
First Online: 22 January 2022
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by the local ethical committee at the University of Antwerp and Antwerp University Hospital. Written informed consent was obtained from all patients.
: Informed consent was obtained from all individual participants included in the study.
: All authors have seen and approved this manuscript. MD holds a Postdoctoral Fellowship at the Research Foundation Flanders (FWO: 12H4520N). MB reports a research grant from SomnoMed at the Antwerp University Hospital. JV seats in the advisory board of ResMed, Bioprojet and MSD. MB seats in the advisory board of ResMed and SomnoMed. OMV reports research support outside the submitted work from Philips, SomnoMed, Inspire Medical Systems and Nyxoah at the Antwerp University Hospital. Consultancy for Galvani and Liva Nova, Advisory Board member for Zephyr and SomnoMed. OMV holds a Senior Clinical Investigator Fellowship from the Research Foundation Flanders (FWO: 1833517 N). The other authors report no competing interests.